These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 36318038)

  • 1. In vitro and in vivo efficacy of tecovirimat against a recently emerged 2022 monkeypox virus isolate.
    Warner BM; Klassen L; Sloan A; Deschambault Y; Soule G; Banadyga L; Cao J; Strong JE; Kobasa D; Safronetz D
    Sci Transl Med; 2022 Nov; 14(673):eade7646. PubMed ID: 36318038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge.
    Russo AT; Berhanu A; Bigger CB; Prigge J; Silvera PM; Grosenbach DW; Hruby D
    Vaccine; 2020 Jan; 38(3):644-654. PubMed ID: 31677948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model.
    Hutson CL; Kondas AV; Mauldin MR; Doty JB; Grossi IM; Morgan CN; Ostergaard SD; Hughes CM; Nakazawa Y; Kling C; Martin BE; Ellison JA; Carroll DS; Gallardo-Romero NF; Olson VA
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33536322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Perspectives on Antimicrobial Agents: Tecovirimat for Treatment of Human Monkeypox Virus.
    DeLaurentis CE; Kiser J; Zucker J
    Antimicrob Agents Chemother; 2022 Dec; 66(12):e0122622. PubMed ID: 36374026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of wild-derived inbred mouse strains highly susceptible to monkeypox virus infection for use as small animal models.
    Americo JL; Moss B; Earl PL
    J Virol; 2010 Aug; 84(16):8172-80. PubMed ID: 20519404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lethal monkeypox virus infection of CAST/EiJ mice is associated with a deficient gamma interferon response.
    Earl PL; Americo JL; Moss B
    J Virol; 2012 Sep; 86(17):9105-12. PubMed ID: 22696658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tecovirimat is effective against human monkeypox virus in vitro at nanomolar concentrations.
    Frenois-Veyrat G; Gallardo F; Gorgé O; Marcheteau E; Ferraris O; Baidaliuk A; Favier AL; Enfroy C; Holy X; Lourenco J; Khoury R; Nolent F; Grosenbach DW; Hruby DE; Ferrier A; Iseni F; Simon-Loriere E; Tournier JN
    Nat Microbiol; 2022 Dec; 7(12):1951-1955. PubMed ID: 36344621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment efficacy of cidofovir and brincidofovir against clade II Monkeypox virus isolates.
    Prévost J; Sloan A; Deschambault Y; Tailor N; Tierney K; Azaransky K; Kammanadiminti S; Barker D; Kodihalli S; Safronetz D
    Antiviral Res; 2024 Nov; 231():105995. PubMed ID: 39243894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol - United States, May-August 2022.
    O'Laughlin K; Tobolowsky FA; Elmor R; Overton R; O'Connor SM; Damon IK; Petersen BW; Rao AK; Chatham-Stephens K; Yu P; Yu Y;
    MMWR Morb Mortal Wkly Rep; 2022 Sep; 71(37):1190-1195. PubMed ID: 36107794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 2022 Monkeypox outbreak: How the medicinal chemistry could help us?
    Silva-Júnior EFD
    Bioorg Med Chem; 2022 Nov; 73():117036. PubMed ID: 36183614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mouse model of lethal infection for evaluating prophylactics and therapeutics against Monkeypox virus.
    Stabenow J; Buller RM; Schriewer J; West C; Sagartz JE; Parker S
    J Virol; 2010 Apr; 84(8):3909-20. PubMed ID: 20130052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of
    Chiem K; Nogales A; Lorenzo M; Morales Vasquez D; Xiang Y; Gupta YK; Blasco R; de la Torre JC; Martínez-Sobrido L
    Microbiol Spectr; 2023 Aug; 11(4):e0474522. PubMed ID: 37278625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tecovirimat Resistance in Mpox Patients, United States, 2022-2023.
    Smith TG; Gigante CM; Wynn NT; Matheny A; Davidson W; Yang Y; Condori RE; O'Connell K; Kovar L; Williams TL; Yu YC; Petersen BW; Baird N; Lowe D; Li Y; Satheshkumar PS; Hutson CL
    Emerg Infect Dis; 2023 Dec; 29(12):2426-2432. PubMed ID: 37856204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak.
    Almehmadi M; Allahyani M; Alsaiari AA; Alshammari MK; Alharbi AS; Hussain KH; Alsubaihi LI; Kamal M; Alotaibi SS; Alotaibi AN; Aldhafeeri AA; Imran M
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of antivirals in the treatment of human monkeypox outbreaks: a systematic review.
    Shamim MA; Padhi BK; Satapathy P; Veeramachaneni SD; Chatterjee C; Tripathy S; Akhtar N; Pradhan A; Dwivedi P; Mohanty A; Rodriguez-Morales AJ; Sah R; Al-Tammemi AB; Al-Tawfiq JA; Nowrouzi-Kia B; Chattu VK
    Int J Infect Dis; 2023 Feb; 127():150-161. PubMed ID: 36470502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Treatment Delay on Efficacy of Tecovirimat Following Lethal Aerosol Monkeypox Virus Challenge in Cynomolgus Macaques.
    Russo AT; Grosenbach DW; Brasel TL; Baker RO; Cawthon AG; Reynolds E; Bailey T; Kuehl PJ; Sugita V; Agans K; Hruby DE
    J Infect Dis; 2018 Sep; 218(9):1490-1499. PubMed ID: 29982575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention and Treatment of Monkeypox: A Systematic Review of Preclinical Studies.
    Sudarmaji N; Kifli N; Hermansyah A; Yeoh SF; Goh BH; Ming LC
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A brief on new waves of monkeypox and vaccines and antiviral drugs for monkeypox.
    Hung YP; Lee CC; Lee JC; Chiu CW; Hsueh PR; Ko WC
    J Microbiol Immunol Infect; 2022 Oct; 55(5):795-802. PubMed ID: 36115792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monkeypox Virus (MPXV) Infection: A Review.
    Kumari R; Arya P; Yadav SP; Mishra RC; Yadav JP
    Infect Disord Drug Targets; 2024; 24(4):76-82. PubMed ID: 38243966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antivirals against monkeypox infections.
    Chiem K; Nogales A; Lorenzo M; Vasquez DM; Xiang Y; Gupta YK; Blasco R; de la Torre JC; Mart Nez-Sobrido L
    bioRxiv; 2023 Apr; ():. PubMed ID: 37131608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.